Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2015 | 09-2014 | 12-2013 | 09-2013 | 09-2007 | |
| Operating Expenses | 3,230 | 654 | 1,183 | 690 | 0 |
| Operating Income | -3,230 | -654 | -1,183 | -690 | N/A |
| Interest Expense | 8 | 93 | 106 | 0 | 0 |
| Other Income | 335 | 9 | 0 | 0 | 0 |
| Pre-tax Income | -2,902 | -738 | -1,288 | -690 | 0 |
| Net Income Continuous | -2,902 | -738 | -1,288 | -690 | N/A |
| Net Income | $-2,902 | $-738 | $-1,288 | $-1,288 | $N/A |
| EPS Basic Total Ops | -34.25 | -14.99 | -26.24 | N/A | N/A |
| EPS Basic Continuous Ops | -34.19 | -14.31 | -27.19 | N/A | N/A |
| EPS Diluted Total Ops | -34.25 | -14.99 | -26.24 | N/A | N/A |
| EPS Diluted Continuous Ops | -34.19 | -14.31 | -27.19 | N/A | N/A |
| EBITDA(a) | $-3,230 | $-640 | $-1,155 | $-690 | $N/A |